Cellevate to pre-launch first nanofiber microcarriers for boosting viral vector production in gene therapy applications at CPHI Milan
LUND, Sweden - Cellevate, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, is ready to pre-launch the world’s 1[st] nanofiber microcarrier for gene therapy at CPHI Milan, October 8-10, 2024.By providing up to 60 times more surface area for cell growth than conventional systems, Cellevat3d[®] nanofiber microcarriers increase yield and productivity in upstream bioprocessing of gene therapy applications. Engineered for stirred tank bioreactors, Cellevat3d[®] nanofiber microcarriers support a wide range of upstream bioprocessing